Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infectious Diseases Research Institute
Seattle, Washington, United Statesidri.org ↗
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
IDRI pioneered adjuvant and vaccine approaches for infectious diseases, most notably conducting the world’s first Phase 1 trials of a recombinant visceral leishmaniasis vaccine and advancing TB and Chagas programs to preclinical and early clinical evaluation. Diagnostics and adjuvant platforms have reached commercial and clinical use in multiple regions.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineSmall moleculeBiologicDiagnostic
- Industry
- Academic Hospital/University/Research
02
Partnerships
GSKBill & Melinda Gates FoundationWalter Reed Army Institute of ResearchAeras Global TB Vaccine FoundationPATH Malaria Vaccine InitiativeAmerican Leprosy MissionsFiocruzMSD Fellowship for Global HealthLilly
Beyond the preview
Go deeper on Infectious Diseases Research Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Infectious Diseases Research Institute.